Search

everythinglearnresearchcommunity

for

Search:↓

Autologous Platelet and Extracellular Vesicle-Rich Plasma (PVRP) has potential in enhancing tissue regeneration and improving hair conditions, but its effectiveness varies due to individual differences.

Regenerative medicine shows promise for treating skin disorders like hair loss and vitiligo.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Oral and topical finasteride are effective and safe for treating female hair loss.

Tiny vesicles from stem cells could be a new treatment for healing wounds.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Regenerative medicine is effective and safe for treating vitiligo.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Stem cell therapies show promise for hair regrowth in androgenetic alopecia.

Microneedling combined with other treatments significantly improves hair growth in people with hair loss and is safe.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

PRP is effective and safe for increasing hair density in people with hair loss.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

Tadalafil and Finasteride may help treat aggressive melanoma.

PRP is an effective and safe treatment for female hair loss.

PRP injections can increase hair density in people with androgenic alopecia.

Curcumin supplements increase adiponectin and decrease leptin in adults.

A substance called Cell-free fat extract can effectively treat common hair loss by increasing hair growth and density.

Wounding may stimulate hair growth, but more research is needed to confirm the safety and effectiveness of related treatments.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The document concludes that while lab results for hair growth promotion are promising, human trials are needed and better testing methods should be developed.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

The book provides detailed information on natural ingredients in beauty products and emphasizes the need for more human trials to confirm their effectiveness.

There are many treatments for common hair loss, but more trials are needed to decide which are best.